EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway

Robert J George1, Mark A Sturmoski, Shrikant Anant

  • 1Washington University School of Medicine, Department of Internal Medicine, St. Louis, Missouri 63110, USA.

Insights

Prostaglandin E2 (PGE2) protects human T-cell leukemia cells from chemotherapy-induced apoptosis via the EP4 receptor. This suggests potential therapeutic strategies targeting PGE2 signaling in cancer treatment.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostaglandin E2 (PGE2) is implicated in various physiological and pathological processes, including cancer.
  • Understanding the role of PGE2 in cancer cell survival is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the anti-apoptotic effects of PGE2 in human T-cell leukemia (Jurkat) cells.
  • To elucidate the specific receptor and downstream signaling pathways involved in PGE2-mediated cytoprotection.

Main Methods:

  • Jurkat cells were incubated with PGE2 (5 nM) before treatment with camptothecin.
  • Apoptosis was assessed by measuring caspase-3 activity and using flow cytometry with propidium iodide staining.
  • Pharmacological inhibitors of EP4 receptor, PI3 kinase, AKT/protein kinase, and protein kinase A were utilized.

Main Results:

  • PGE2 pre-incubation significantly reduced camptothecin-induced caspase-3 activity by 30% and apoptosis by 35%.
  • The EP4 receptor was identified as the mediator of PGE2's protective effect against camptothecin-induced apoptosis.
  • Inhibition of PI3 kinase or AKT/protein kinase, but not protein kinase A, blocked the cell survival effect of PGE2.

Conclusions:

  • PGE2 confers significant protection against chemotherapy-induced apoptosis in Jurkat cells.
  • The EP4 receptor and the PI3K/AKT signaling pathway are critical for mediating PGE2's anti-apoptotic effects.
  • Targeting EP4 receptor signaling presents a potential therapeutic avenue for enhancing cancer treatment efficacy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.